Hot Topics

PHUSE collaborations are organised into a number of specialist Working Groups, each with a broad topic area. The Working Groups have specific projects designed to achieve a set of particular objectives. This page will highlight the latest news and information from our projects. Participation is open to anyone who wants to contribute and if you would like to get involved, please email workinggroups@phuse.global.

The Safety Analytics Working Group will be delivering a series of virtual, free to attend webinars over the coming months. The third webinar will take place on 14 September on the topic of Safety Analytics Webinar Series: Overall Safety Assessment – AE Groupings for Assessment of Safety Topics of Interest Click here to register for this webinar.  A list of all upcoming webinars and previous webinars can be found here. 

The Real World Evidence Working Group hosted a Community Forum on Designing your RWD Study: Is Your Data Fit For Purpose? Rest assured if you couldn't attend, the recording is available to view now!

Real World Evidence Working Group’s new project, Real World Data Guideline/White Paper for Statistical Programmers is now calling for volunteers. The aim of this project is for statistical programmers across pharma to collaborate and provide their input to create an RWE Guideline/White Paper for the industry. 

Data Transparency Working Group's new project Anonymization of Imaging Data is now calling for volunteers. This project plans to complete a literature review on types of imaging files including (X-rays, (f)MRIs, CT scans, etc.), their formats (DICOM, NIfTI, etc.), their positions (limbs, heads, organs, etc.) and all associated metadata. There will also be a discussion on data handling, storage and transfer. Any existing guidance and repositories will be reviewed. We will then focus on use cases that will have the most impact based on interest and complexity. 

Real World Evidence Working Group's Project Real World Evidence Guidance have created a 5-minute survey to asses interest, identify preferred methods of communication and gather initial questions to be raised through their open source platform for addressing queries relating to RWD. The Real World Evidence Guidance have also compiled a collection of frequently asked questions about using Real World Evidence. Check out the Real World Evidence Guidance Q&A page to see some of the teams' responses and the schedule of upcoming questions.

Please contact workinggroups@phuse.global to register your interest in volunteering.

The Cloud Adoption in the Life Sciences Industry project has made an update to their Cloud Framework, Pre-Amble White Paper. Since the original publication of this framework, adoption of the public cloud by Life Sciences has become necessary, and no longer the exception. As part of this foreseeable evolution, there has been a significant rise in the construction of hybrid and/or multi-cloud systems. This framework outlines these approaches leveraging well recognised concepts. The team are calling for feedback on the White Paper, please provide any comments to workinggroups@phuse.global by 23 August. 

The Julia Initiative for High Performance Computing project have produced a White Paper providing an overview of Julia's features and benefits for high performance computing, including its fast compilation, dynamic typing, multiple dispatch, and built-in support for parallelism. This paper also discusses current real-world use cases of Julia and potential case studies for high performance computing. The team are calling for feedback on the White Paper, please provide any comments to workinggroups@phuse.global by 7 August. 

Initiate and lead a new project under the PHUSE Working Groups umbrella. The new project must address problems of significant relevance to computational science related to drug, biologic and device development and must meet all of the guidelines for projects within the collaboration, including the following mandatory requirements: 

• The projects must address significant research issues relevant to Computational Science
• The project must not attempt to address FDA policy issues
• There must be at least one Project Lead personally involved in planning and carrying out the project

New projects can be submitted anytime during the year, click here to submit. 

Working Groups Report: Includes project updates, recent and upcoming deliverables and the future plans for each Working Group.

Monthly Mailings: The monthly newsletter. Here you will find a full update from each month of the year, easily accessible and divided into key areas of PHUSE.